CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $93 | +60.3% | 2,041 | +97.4% | 0.03% | +50.0% |
| Q2 2023 | $58 | +20.8% | 1,034 | -2.9% | 0.02% | +12.5% |
| Q1 2023 | $48 | -67.1% | 1,065 | -70.4% | 0.02% | -72.9% |
| Q4 2022 | $146 | -100.0% | 3,598 | -85.4% | 0.06% | -91.3% |
| Q3 2022 | $1,606,000 | +1882.7% | 24,583 | +1744.2% | 0.68% | +1888.2% |
| Q2 2022 | $81,000 | -3.6% | 1,333 | 0.0% | 0.03% | +13.3% |
| Q1 2022 | $84,000 | – | 1,333 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |